Volume 6 (2021)
Volume 5 (2020)
Volume 4 (2019)
1. Evaluation of LBX-2AS1 Gene Expression in Patients with Colorectal Cancer
Volume 6, Issue 23 , December 2021, Pages 1-4
Abstract
Colorectal Cancer (CRC) is the third most common cancer in Iranian men and the fourth most common cancer in women. Recent studies have shown that lncRNAs may also engage in remodeling ... Read More
2. Methylenetetrahydrofolate Reductase C677T (rs1801133) Polymorphism and Pemetrexed Treatment Outcome in Patients with Non–Small-Cell Lung Cancer
Volume 6, Issue 23 , December 2021, Pages 5-9
Abstract
Background: Lung cancer is the first cause of cancer deaths in the world. Pemetrexed is an antifolate drug used as a first or second-line in the treatment of advanced non-small cell ... Read More
3. Personal Medicine Possible Treatment of Breast Cancer
Volume 6, Issue 23 , December 2021, Pages 10-16
Abstract
Personal medicine is based on purposeful treatment that, unlike traditional therapies, considers a person's genetic structure and medical history before establishing a treatment regimen. ... Read More
4. Induction of Bax and Caspase-3 Genes Expression by Simultaneous Administration of Phycocyanin and Citrullus Colocynthis Extract in Human Colorectal Cell Line (HT-29)
Volume 6, Issue 23 , December 2021, Pages 17-24
Abstract
Introduction: In this study the effect of C. colocynthis extract and phycocyanin on the growth of colon cancer cells, and the expression of Caspase 3 and Bax were investigated.Materials ... Read More
5. Polycystic ovary syndrome and genetic factors influencing its development: A review article
Volume 6, Issue 23 , December 2021, Pages 25-29
Abstract
Polycystic ovary syndrome (PCOS) is a common infertility disorder, affecting a significant proportion of the global population. This syndrome has been one of the most controversial ... Read More
6. The Impact of Nanotechnology on the Future of Personalized Medicine
Volume 6, Issue 23 , December 2021, Pages 30-34